| Year |
Citation |
Score |
| 2024 |
Mineva ND, Pianetti S, Das SG, Srinivasan S, Billiald NM, Sonenshein GE. A Novel Class of Human ADAM8 Inhibitory Antibodies for Treatment of Triple-Negative Breast Cancer. Pharmaceutics. 16. PMID 38675197 DOI: 10.3390/pharmaceutics16040536 |
0.627 |
|
| 2023 |
Pianetti S, Miller KD, Chen HH, Althouse S, Cao S, Michael SJ, Sonenshein GE, Mineva ND. ADAM8 is expressed widely in breast cancer and predicts poor outcome in hormone receptor positive, HER-2 negative patients. Cancer Cell International. 23: 165. PMID 37568162 DOI: 10.1186/s12935-023-03024-3 |
0.66 |
|
| 2016 |
Lyons J, Polmear M, Mineva ND, Romagnoli M, Sonenshein GE, Georgakoudi I. Endogenous light scattering as an optical signature of circulating tumor cell clusters. Biomedical Optics Express. 7: 1042-50. PMID 27231606 DOI: 10.1364/Boe.7.001042 |
0.533 |
|
| 2016 |
Das SG, Romagnoli M, Mineva ND, Barillé-Nion S, Jézéquel P, Campone M, Sonenshein GE. miR-720 is a downstream target of an ADAM8-induced ERK signaling cascade that promotes the migratory and invasive phenotype of triple-negative breast cancer cells. Breast Cancer Research : Bcr. 18: 40. PMID 27039296 DOI: 10.1186/S13058-016-0699-Z |
0.664 |
|
| 2014 |
Romagnoli M, Mineva ND, Polmear M, Conrad C, Srinivasan S, Loussouarn D, Barillé-Nion S, Georgakoudi I, Dagg Ã, McDermott EW, Duffy MJ, McGowan PM, Schlomann U, Parsons M, Bartsch JW, et al. ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis. Embo Molecular Medicine. 6: 278-94. PMID 24375628 DOI: 10.1002/Emmm.201303373 |
0.645 |
|
| 2013 |
Mineva ND, Paulson KE, Naber SP, Yee AS, Sonenshein GE. Epigallocatechin-3-gallate inhibits stem-like inflammatory breast cancer cells. Plos One. 8: e73464. PMID 24039951 DOI: 10.1371/Journal.Pone.0073464 |
0.665 |
|
| 2009 |
Wang X, Belguise K, O'Neill CF, Sánchez-Morgan N, Romagnoli M, Eddy SF, Mineva ND, Yu Z, Min C, Trinkaus-Randall V, Chalbos D, Sonenshein GE. RelB NF-kappaB represses estrogen receptor alpha expression via induction of the zinc finger protein Blimp1. Molecular and Cellular Biology. 29: 3832-44. PMID 19433448 DOI: 10.1128/Mcb.00032-09 |
0.694 |
|
| 2009 |
Mineva ND, Wang X, Yang S, Ying H, Xiao ZX, Holick MF, Sonenshein GE. Inhibition of RelB by 1,25-dihydroxyvitamin D3 promotes sensitivity of breast cancer cells to radiation. Journal of Cellular Physiology. 220: 593-9. PMID 19373868 DOI: 10.1002/Jcp.21765 |
0.707 |
|
| 2008 |
Chandramohan V, Mineva ND, Burke B, Jeay S, Wu M, Shen J, Yang W, Hann SR, Sonenshein GE. c-Myc represses FOXO3a-mediated transcription of the gene encoding the p27(Kip1) cyclin dependent kinase inhibitor. Journal of Cellular Biochemistry. 104: 2091-106. PMID 18393360 DOI: 10.1002/Jcb.21765 |
0.646 |
|
| 2007 |
Mineva ND, Rothstein TL, Meyers JA, Lerner A, Sonenshein GE. CD40 ligand-mediated activation of the de novo RelB NF-kappaB synthesis pathway in transformed B cells promotes rescue from apoptosis. The Journal of Biological Chemistry. 282: 17475-85. PMID 17446175 DOI: 10.1074/Jbc.M607313200 |
0.593 |
|
| 2007 |
Wang X, Belguise K, Kersual N, Kirsch KH, Mineva ND, Galtier F, Chalbos D, Sonenshein GE. Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2. Nature Cell Biology. 9: 470-8. PMID 17369819 DOI: 10.1038/Ncb1559 |
0.723 |
|
| 2003 |
Thiagalingam S, Cheng KH, Lee HJ, Mineva N, Thiagalingam A, Ponte JF. Histone deacetylases: unique players in shaping the epigenetic histone code. Annals of the New York Academy of Sciences. 983: 84-100. PMID 12724214 DOI: 10.1111/J.1749-6632.2003.Tb05964.X |
0.331 |
|
| Show low-probability matches. |